Eric W. Dittmann is Global Vice Chair of the Intellectual Property Practice, overseeing the firm’s 100-plus lawyer IP practice, and is based in the firm’s New York office. Mr. Dittmann focuses his practice on life sciences patent litigation and post-grant proceedings and has significant experience with a broad range of technologies in the pharmaceutical, biotechnology, and medical device fields. He has been recognized as a leading patent litigator by numerous publications, including The Legal 500, IAM Patent 1000, Benchmark Litigation, LMG Life Sciences, and Managing Intellectual Property.
Paul Hastings Nominated for Four LMG Life Sciences Awards
July 26, 2019
Paul Hastings Recognized in 2019 Managing Intellectual Property’s IP Stars
June 24, 2019
Paul Hastings Recognized in 2019 IAM Patent 1000 as One of the Most Sophisticated Patent Litigation Practices
June 07, 2019
New York Law Journal Recognizes Paul Hastings Life Sciences IP Litigators as New York Trailblazers
May 20, 2019
Paul Hastings Wins Top Honors at 2019 Managing IP Americas Awards
April 08, 2019
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2018
October 11, 2018
Paul Hastings Wins Hatch-Waxman Litigation Firm of the Year at LMG Life Sciences Awards
September 13, 2018
Paul Hastings Recognized in 2018 Managing Intellectual Property IP Stars
June 18, 2018
Paul Hastings Named Transatlantic IP Team of the Year by The American Lawyer
June 15, 2018
Paul Hastings Recognized in 2018 IAM Patent 1000 For Superb Track Record in Patent Litigation
June 15, 2018
Paul Hastings Wins Law360 Life Sciences Practice Group of the Year
February 05, 2018
Paul Hastings Scores Top Rankings in LMG Life Sciences for 2016
November 30, 2016
Senate Judiciary Committee Passes Bill Limiting the Number of Patents for BPCIA Litigation
July 03, 2019
Generic Found to Infringe Valid Patent Claims Covering Helsinn’s Aloxi® Product
February 21, 2017
Federal Circuit Rejects Application of the On-Sale Bar to Contract Manufacturers
July 11, 2016
Federal Circuit Issues Expansive Ruling in Upholding Jurisdiction over Mylan in Delaware
March 18, 2016
Supreme Court Ruling in Alice v. CLS Bank Continues Framework for Patent Eligibility Set Forth in Mayo v. Prometheus
June 19, 2014
Today's Gilead Federal Circuit Decision Is a Significant Change to Double-Patenting Law
April 22, 2014
Federal Circuit Clarifies That Foreseeability Does Not Preclude the Application of the Doctrine of Equivalents
February 20, 2014
How Will H.R. 3309 (the Innovation Act) Impact Pharmaceutical and Biotechnology Patent Cases?
October 29, 2013
In an Issue of First Impression, the Federal Circuit Finds Infringement as a Matter of Law Despite a Sworn Certification Promising No Infringement
September 26, 2013
The Federal Circuit Further Clarifies The Obviousness-Type Double Patenting Doctrine For Composition Claims
August 27, 2012
Federal Circuit Reaffirms Patentability of Isolated DNA Molecules in View of Supreme Courts Mayo v. Prometheus Decision
August 17, 2012
Federal Circuit Signals Reigning in of Janssen and Rasmusson on Enablement/Utility
August 01, 2011
Failure to Launch
April 07, 2011
Second Circuit Cipro Decision Affirms No Per Se Antitrust Violation for Reverse-Payment Settlements, but Invites Petition for Rehearing En Banc
May 03, 2010
Patent Owner Protected by Safe Harbor Provision
January 27, 2010
Recognized by Managing IP as the Life Sciences IP Litigation Firm of the Year
Paul Hastings was was recognized by Managing IP at their Americas Awards, which honored individuals and companies behind the most innovative and challenging IP work of the past year, as well as those driving the international IP market.
The firm was recognized as Life Sciences IP Litigation Firm of the Year in the United States.
April 05, 2019
Recognized as the 2019 Post-Grant Firm of the Year by IAM Magazine
Paul Hastings was recognized as the Post-Grant Firm of the Year at Intellectual Asset Management's inaugural Global IP Awards. The award recognizes the achievements of the firm's Patent Trial and Appeal Board (PTAB) Team, which practices before the US Patent & Trial Office. Over the past year, the team's accomplishments include numerous post-grant proceeding victories for technology and life sciences clients - four of which were affirmed by the Court of Appeals for the Federal Circuit.
January 30, 2019
Recognized as LMG Life Sciences Stars for 2018
Paul Hastings was recognized in the 2018 edition of LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Eric Dittmann, Gary Giampetruzzi, Naveen Modi, Joseph O’Malley, Chad Peterman, Preston Ratliff, and Bruce Wexler. Earlier this year, LMG Life Sciences honored the firm with the LMG Life Sciences award for Hatch-Waxman Litigation Firm of the Year – Branded.
October 12, 2018
Recognized as the Hatch-Waxman Litigation Firm of the Year by LMG Life Sciences
LMG Life Sciences announced that the firm’s Intellectual Property practice was honored at the LMG Life Sciences Awards as the Hatch-Waxman Litigation Firm of the Year (Branded). The publication cited the firm for wins on behalf of Sunovion Pharmaceuticals, which locked in compound patent protection for Latuda®, the company’s billion-dollar-plus-per-year schizophrenia and bipolar drug, after a judgment of infringement that was affirmed by the Federal Circuit; and for Orexigen Therapeutics after a trial victory where the judge found all three patents-in-suit to be valid and infringed. The firm was also noted for obtaining an unprecedented six walk-away consent judgments in a major pharmaceutical litigation.
The firm and its partners were also shortlisted for:
* Inter-Partes Review Firm of the Year
* Post Grant Proceedings Attorney of the Year: Naveen Modi
* General Patent Litigator of the Year – New York: Bruce Wexler
September 13, 2018
Recognized as the Transatlantic IP Team of the Year by The American Lawyer
The American Lawyer named Paul Hastings its Transatlantic IP Team of the Year at the Transatlantic Legal Awards. The practice was honored due to Bruce Wexler, Eric Dittmann, and Isaac Ashkenazi leading a team in a major pharmaceutical litigation through fact, expert and Markman phases, and obtaining six walk-away consent judgments.
The awards consider the top legal work between the U.S. and the U.K. and European legal markets, recognizing law firms for “excellence in handling transatlantic matters across the key areas of corporate, finance, and disputes, as well as highlighting law firm innovation, commitment to pro bono, outstanding transatlantic strategy, and in-house leaders.”
June 15, 2018
Recognized as Law360 Practice Group of the Year in Life Sciences
Paul Hastings was named as a Practice Group of the Year in Life Sciences by Law360. The article noted Paul Hastings’ undefeated track record in life sciences cases at the Patent Trial and Appeal Board, including victories on behalf of Acorda Therapeutics, which won four inter partes reviews against Kyle Bass’ Coalition for Affordable Drugs. Law360 also highlighted the representation of Galena Biopharma in a civil-only settlement resolving investigations regarding Galena’s past promotional practices for Abstral, a rapid onset opioid product. The winners were chosen from nearly 750 submissions, and are recognized as "firms that racked up victories in litigation and closed the big deals to make their mark among clients and throughout the legal industry."
February 01, 2018
Recognized as LMG Life Sciences Stars for 2017
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation.
LMG Life Sciences selected seven individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler, Gerald Flattmann, Naveen Modi, Chad Peterman, Eric Dittmann, and Gary Giampetruzzi.
October 06, 2017
Recognized as LMG Life Sciences Stars for 2016
Paul Hastings was recognized in LMG Life Sciences, with Highly Recommended rankings for General Patent Litigation and Hatch-Waxman Branded Litigation. LMG Life Sciences selected six individual lawyers as "Life Sciences Stars," including Joseph O’Malley, Bruce Wexler,
Gerald Flattmann, Gary Giampetruzzi, Naveen Modi, and Eric Dittmann.
November 30, 2016
Recognized at the 2016 LMG Life Sciences Awards
Paul Hastings was recognized with multiple LMG Life Sciences Awards. Bruce Wexler was named “General Patent Litigator of the Year – New York” and Naveen Modi was recognized as Post Grant Proceedings Attorney of the Year. The Life Sciences Patent Litigation practice also won awards for two Hatch-Waxman Impact Cases of the Year, including Helsinn Healthcare SA v. Teva Pharmaceuticals USA, a win resolving a long-running patent dispute over Aloxi®, a drug used to treat chemotherapy-induced nausea and vomiting.
The Paul Hastings team representing Helsinn was led by Joseph O’Malley. The firm was also honored for its work on behalf of Eli Lily in Sanofi-Aventis US v. Eli Lilly & Co., where Bruce Wexler led the team representing Eli Lily in litigation regarding the marketing of Basaglar®, its insulin glargine drug product. The case was settled in late 2015, with the press reporting Eli Lilly’s ability to launch the drug.
September 16, 2016
Shortlisted for four LMG Life Sciences Awards for 2016
The Firm was shortlisted in four categories for the LMG Life Sciences Awards. Joseph O’Malley was nominated in the Hatch-Waxman Litigator of the Year – Branded category, Bruce Wexler was nominated in the General Patent Litigator of the Year - New Yorkcategory, Naveen Modi was nominated in the Post Grant Proceedings Attorney of the Year category, and the Firm was nominated in the “Hatch-Waxman Litigation Firm of the Year – Branded” category.
July 27, 2016
Recognized as a Law360 Rising Star in Life Sciences
Eric Dittmann was recognized by Law360 as a rising star in its annual list of top attorneys in Life Sciences.
March 30, 2015
Legal Media Group's 2013 LMG Life Science Awards
The firm was nominated as a 2013 LMG Life Science nominee in the “Litigation Team of the Year” and “(General) Patent Litigation: Firm of the Year” categories.
August 12, 2013
Intellectual Property Magazine
Intellectual Property Magazine recognized Paul Hastings' IP Pharmaceutical Team as the Pharmaceutical Team of the Year.
November 30, 2010